Elevated serum levels of interleukin-12 in chronic progressive multiple sclerosis
Ferdinando Nicoletti(University of Catania), A. Reggio(University of Catania), Paola Zaccone(University of Catania), Alessandra Nicoletti(University of Catania), Roberto Di Marco(University of Catania), Francesco Patti(University of Catania), Clementina Cocuzza(University of Milano-Bicocca)
Cited by 114
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508
The neuropathic pain: An overview of the current treatment and future therapeutic approaches
|International Journal of Immunopathology and Pharmacology|2019|495